[{"id":"fffdbde6-56a8-452b-bbea-6d93185cfd92","acronym":"","url":"https://clinicaltrials.gov/study/NCT04928677","created_at":"2021-06-16T18:52:52.175Z","updated_at":"2024-07-02T16:35:44.506Z","phase":"Phase 1","brief_title":"A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment","source_id_and_acronym":"NCT04928677","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e codrituzumab (RG7686)"],"overall_status":"Recruiting","enrollment":" Enrollment 50","initiation":"Initiation: 06/09/2021","start_date":" 06/09/2021","primary_txt":" Primary completion: 06/01/2025","primary_completion_date":" 06/01/2025","study_txt":" Completion: 06/01/2025","study_completion_date":" 06/01/2025","last_update_posted":"2023-06-28"},{"id":"19a59b05-6fa7-49a1-a054-e38013d0c27a","acronym":"","url":"https://clinicaltrials.gov/study/NCT01507168","created_at":"2021-01-18T06:20:00.730Z","updated_at":"2024-07-02T16:36:46.674Z","phase":"Phase 2","brief_title":"A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma","source_id_and_acronym":"NCT01507168","lead_sponsor":"Hoffmann-La Roche","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e codrituzumab (RG7686)"],"overall_status":"Completed","enrollment":" Enrollment 185","initiation":"Initiation: 02/02/2012","start_date":" 02/02/2012","primary_txt":" Primary completion: 08/20/2015","primary_completion_date":" 08/20/2015","study_txt":" Completion: 08/20/2015","study_completion_date":" 08/20/2015","last_update_posted":"2020-04-03"}]